Now, what big pharmaceutical is going to partner up and take Remplir into phase 3 trials in the US, we are so close yet so far, let’s hope towards the second half of the year or early next year
Such a waste, where Remplir could be doing good, with thousand of patients losing out because of the approval process / commercialisation process taking so long, let’s try and fast track this process and get Remplir to market
Media thread, page-154
-
- There are more pages in this discussion • 414 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $82.68M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 39.5¢ | $12.32K | 31.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12248 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 759 | 1 |
View Market Depth
| Last trade - 10.36am 12/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |